Predictions
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€0.087
12.08.23
12.08.23
-
12.08.24
12.08.24
48.28%
08.09.23
08.09.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.08
07.08.23
07.08.23
-
07.08.24
07.08.24
-1.10%
19.08.23
19.08.23
Risky Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.03
08.07.23
08.07.23
-
08.07.24
08.07.24
-18.91%
26.11.23
26.11.23
Could be worthwhile Investment >10% per year
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€0.11
25.06.23
25.06.23
-
25.06.24
25.06.24
13.16%
08.09.23
08.09.23
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.29
25.06.23
25.06.23
-
25.06.24
25.06.24
-21.77%
06.07.23
06.07.23
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€0.13
17.06.23
17.06.23
-
17.06.24
17.06.24
1.57%
08.09.23
08.09.23
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.35
17.06.23
17.06.23
-
17.06.24
17.06.24
-33.91%
06.07.23
06.07.23
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.00
19.05.23
19.05.23
€2.20
19.05.24
19.05.24
-63.20%
01.10.23
01.10.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€0.44
30.04.23
30.04.23
-
30.04.24
30.04.24
-70.95%
01.05.24
01.05.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.43
30.04.23
30.04.23
-
30.04.24
30.04.24
-47.00%
01.05.24
01.05.24
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€0.55
22.04.23
22.04.23
-
22.04.24
22.04.24
-76.33%
23.04.24
23.04.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.41
22.04.23
22.04.23
-
22.04.24
22.04.24
-43.90%
23.04.24
23.04.24
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.80
03.04.23
03.04.23
-
03.04.27
03.04.27
-12.14%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.87
24.03.23
24.03.23
-
24.03.24
24.03.24
12.58%
18.05.23
18.05.23
Could be very worthwhile Investment >20% year
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.30
20.03.23
20.03.23
-
20.03.24
20.03.24
6.18%
23.03.23
23.03.23
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.22
11.03.23
11.03.23
€4.60
11.03.24
11.03.24
18.48%
19.05.23
19.05.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
05.03.23
05.03.23
-
05.03.24
05.03.24
-35.75%
06.03.24
06.03.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
26.02.23
26.02.23
-
26.02.24
26.02.24
-35.75%
27.02.24
27.02.24
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.46
04.01.23
04.01.23
€12.00
31.12.25
31.12.25
63.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.55
03.01.23
03.01.23
-
03.01.24
03.01.24
78.44%
14.05.23
14.05.23
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.80
19.11.22
19.11.22
€2.00
19.11.23
19.11.23
-41.00%
20.11.23
20.11.23
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.34
12.09.22
12.09.22
-
12.09.23
12.09.23
-93.70%
02.04.23
02.04.23
Could be very worthwhile Investment >20% year